03.3
Contacts and Imprint
CONTACTS
FRESENIUS MEDICAL CARE
61346 Bad Homburg v.d.H. INVESTOR RELATIONS
OLIVER MAIER GERRIT JOST |
NORD AMERIKA
|
IMPRINT
Subject to change.
This annual report is also available in German and may be obtained from the Company upon request.
Dieser Geschäftsbericht liegt auch in deutscher Sprache vor.
Annual reports, interim reports, and further information on the Company are also available on our Web site: http://www.fmc-ag.com. Printed reports can be ordered online, by phone or in writing from Investor Relations.
Published by Fresenius Medical Care AG & Co. KGaA
Editorial office Investor Relations
Editorial deadline March 12, 2009
Copy editing Textpertise, Heike Virchow
Concept and design häfelinger + wagner design, Munich
Photographer Matthias Ziegler
Produced by Graphische Betriebe Eberl GmbH, Immenstadt i. Allgäu
This report contains forward-looking statements that are based on plans, projections and estimates and subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors. The risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA’s reports filed with the U.S. Securities and Exchange Commission. We do not undertake any obligation to update any forward-looking statements in this report.
The title, text, and illustrations are subject to copyright. Reproduction in whole or in part requires the prior written authorization of Fresenius Medical Care AG & Co. KGaA.
Fresenius Medical Care AG & Co. KGaA
Registered seat and commercial register: Hof an der Saale (Germany),
HRB 4019
Chairman of the Supervisory Board: Dr. Gerd Krick
General partner: Fresenius Medical Care Management aAGg
Registered seat and commercial register: Hof an der Saale (Germany),
HRB 3894
Management Board: Dr. Ben Lipps (Chairman), Roberto Fusté,
Dr. Emanuele Gatti, Rice Powell, Lawrence A. Rosen, Dr. Rainer Runte,
Mats Wahlstrom
Chairman of the Supervisory Board: Dr. Ulf M. Schneider
